Trifasciatoside A - Compound Card

Trifasciatoside A

Select a section from the left sidebar

Trifasciatoside A

Structure
Zoomed Structure
  • Family: Plantae - Dracaenaceae
  • Kingdom: Plantae
  • Class: Steroid
    • Subclass: Saponin
Canonical Smiles OC[C@H]1O[C@@H](O[C@@H]2C[C@H](O)CC3=CC[C@@H]4[C@@H]([C@@]23C)CC[C@]2([C@H]4C[C@H]3[C@@H]2[C@H](C)[C@]2(O3)CC[C@@](O2)(C)CO[C@@H]2O[C@H](CO)[C@H]([C@@H]([C@H]2O)O)O)C)[C@@H]([C@H]([C@@H]1O)O[C@@H]1OC[C@H]([C@@H]([C@H]1O)O)O)O[C@@H]1O[C@@H](C)[C@@H]([C@H]([C@H]1O)O)O
InChI InChI=1S/C50H80O23/c1-19-31-27(72-50(19)11-10-47(3,73-50)18-65-44-39(62)37(60)34(57)28(15-51)67-44)14-25-23-7-6-21-12-22(53)13-30(49(21,5)24(23)8-9-48(25,31)4)69-46-42(71-45-40(63)36(59)32(55)20(2)66-45)41(35(58)29(16-52)68-46)70-43-38(61)33(56)26(54)17-64-43/h6,19-20,22-46,51-63H,7-18H2,1-5H3/t19-,20-,22+,23+,24-,25-,26+,27-,28+,29+,30+,31-,32-,33-,34+,35+,36+,37-,38+,39+,40+,41-,42+,43-,44+,45-,46-,47-,48-,49-,50-/m0/s1
InChIKey IFIRIVWJDDUGKQ-XVUIIYJASA-N
Formula C50H80O23
HBA 23
HBD 13
MW 1049.17
Rotatable Bonds 11
TPSA 355.29
LogP -3.24
Number Rings 10
Number Aromatic Rings 0
Heavy Atom Count 73
Formal Charge 0
Fraction CSP3 0.96
Exact Mass 1048.51
Number of Lipinski Rule Violations 3
# Species Family Kingdom NCBI Taxonomy ID
1 Sansevieria trifasciata Dracaenaceae Plantae 39534

Showing of synonyms

  • Teponno RB, Tanaka C, et al. (2016). Trifasciatosides A-J, Steroidal Saponins from Sansevieria trifasciata.. Chemical & pharmaceutical bulletin,2016, 64(9), 1347-1355. [View] [PubMed]
Pubchem: 132580503

No compound-protein relationship available.

Structure

SMILES: O1CCCCC1OCC(O2)CCC23CC4C5C(CC4O3)C6C(CC5)C7C(=CC6)CCCC7OC8OCCC(OC9CCCCO9)C8OC1CCCCO1

Level: 4

Mol. Weight: 1049.17 g/mol

Structure

SMILES: O1CCCCC1OCC(O2)CCC23CC4C5C(CC4O3)C6C(CC5)C7C(=CC6)CCCC7OC(OCCC8)C8OC9CCCCO9

Level: 3

Mol. Weight: 1049.17 g/mol

Structure

SMILES: O1CCCCC1OCC(O2)CCC23CC4C5C(CC4O3)C6C(CC5)C7C(=CC6)CCCC7OC(OCC8)CC8OC9CCCCO9

Level: 3

Mol. Weight: 1049.17 g/mol

Structure

SMILES: O1CCCC12CC3C4C(CC3O2)C5C(CC4)C6C(=CC5)CCCC6OC7OCCC(OC8CCCCO8)C7OC9CCCCO9

Level: 3

Mol. Weight: 1049.17 g/mol

Structure

SMILES: O1CCCCC1OCC(O2)CCC23CC4C5C(CC4O3)C6C(CC5)C7C(=CC6)CCCC7OC8CCCCO8

Level: 2

Mol. Weight: 1049.17 g/mol

Structure

SMILES: O1CCCC12CC3C4C(CC3O2)C5C(CC4)C6C(=CC5)CCCC6OC(OCCC7)C7OC8CCCCO8

Level: 2

Mol. Weight: 1049.17 g/mol

Structure

SMILES: O1CCCC12CC3C4C(CC3O2)C5C(CC4)C6C(=CC5)CCCC6OC(OCC7)CC7OC8CCCCO8

Level: 2

Mol. Weight: 1049.17 g/mol

Structure

SMILES: O1CCCCC1OC2C(COCC2)OC3CCCCO3

Level: 2

Mol. Weight: 1049.17 g/mol

Structure

SMILES: O1CCCCC1OCC(O2)CCC23CC4C5C(CC4O3)C6C(CC5)C7C(=CC6)CCCC7

Level: 1

Mol. Weight: 1049.17 g/mol

Structure

SMILES: O1CCCC12CC3C4C(CC3O2)C5C(CC4)C6C(=CC5)CCCC6OC7CCCCO7

Level: 1

Mol. Weight: 1049.17 g/mol

Structure

SMILES: C1OCCCC1OC2CCCCO2

Level: 1

Mol. Weight: 1049.17 g/mol

Structure

SMILES: C1COCCC1OC2CCCCO2

Level: 1

Mol. Weight: 1049.17 g/mol

Structure

SMILES: O1CCCC12CC3C4C(CC3O2)C5C(CC4)C6C(=CC5)CCCC6

Level: 0

Mol. Weight: 1049.17 g/mol

Structure

SMILES: C1CCOCC1

Level: 0

Mol. Weight: 1049.17 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-6.61
Human Oral Bioavailability 20%
Non-Bioavailable
Human Intestinal Absorption
Non-Absorbed
Madin-Darby Canine Kidney
213432.780
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
27894036.84

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.730
Plasma Protein Binding
72.92
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
1.000
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Toxic
Bee
Safe
Bioconcentration Factor
-648744.520
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Toxic
Liver Injury I (DILI)
Toxic
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
-1.350
Liver Injury II
Safe
hERG Blockers
Toxic
Daphnia Maga
4.050
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-50626332649.980
Rat (Acute)
3.930
Rat (Chronic Oral)
108.360
Fathead Minnow
63904967.440
Respiratory Disease
Toxic
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
5694053654.640
Hydration Free Energy
-2.920
Log(D) at pH=7.4
-3153.620
Log(P)
-1.56
Log S
-2.28
Log(Vapor Pressure)
-187502106.17
Melting Point
243.59
pKa Acid
-1366149.85
pKa Basic
-10974.0

No predicted protein targets found for this compound.

Download SDF